GT
AZN icon

Glenview Trust’s AstraZeneca AZN Stock Holding History

Glenview Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$779K Sell
3,950
-12
-0.3% -$2.31K 0.01% 320
2025
Q4 		$728K Buy
3,962
+1,565
+65% +$274K 0.01% 320
2025
Q3 		$368K Sell
2,397
-157
-6% -$23.8K 0.01% 405
2025
Q2 		$357K Buy
2,554
+383
+18% +$53.7K 0.01% 406
2025
Q1 		$319K Sell
2,171
-36
-2% -$5.21K 0.01% 404
2024
Q4 		$289K Sell
2,207
-8
-0.4% -$1.12K 0.01% 420
2024
Q3 		$345K Sell
2,215
-611
-22% -$98.6K 0.01% 398
2024
Q2 		$441K Buy
2,826
+498
+21% +$74.9K 0.01% 368
2024
Q1 		$315K Sell
2,328
-61
-3% -$8.08K 0.01% 391
2023
Q4 		$322K Buy
2,389
+27
+1% +$3.51K 0.01% 392
2023
Q3 		$320K Buy
2,362
+87
+4% +$11.9K 0.01% 370
2023
Q2 		$326K Buy
2,275
+86
+4% +$12.7K 0.01% 374
2023
Q1 		$304K Hold
2,189
– – 0.01% 374
2022
Q4 		$297K Buy
2,189
+110
+5% +$13.8K 0.01% 368
2022
Q3 		$228K Buy
+2,079
New +$264K 0.01% 381
2021
Q4 		– Sell
-3,086
Closed -$371K – 416
2021
Q3 		$371K Buy
+3,086
New +$359K 0.01% 313
2013
Q4 		$358K Buy
+6,024
New +$327K 0.04% 164

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Glenview Trust's AZN Position: Q1 2026 in Review

Glenview Trust reduced its AstraZeneca (AZN) stake by 0.3% in Q1 2026, selling an estimated $2.31K and leaving 3,950 shares worth $779K. The position accounts for 0.01% of the portfolio, ranked #320.

Glenview Trust first reported a position in AZN in Q4 2013 and has held it in 17 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Glenview Trust held 3,950 shares of AstraZeneca worth $779K as of Q1 2026.
  • Glenview Trust sold 12 AstraZeneca shares in Q1 2026, an estimated $2.31K.
  • AstraZeneca made up 0.01% of Glenview Trust's portfolio in Q1 2026, its #320 holding.
  • Glenview Trust first reported a position in AstraZeneca in Q4 2013 and has held it in 17 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.